Immediate Impact
1 by Nobel laureates 9 from Science/Nature 62 standout
Citing Papers
Hallmarks of neurodegenerative diseases
2023 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of C Raby being referenced
Traumatic Brain Injury Increases β‐Amyloid Peptide 1‐42 in Cerebrospinal Fluid
1998
Chapter 54: Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease
1993
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| C Raby | 169 | 72 | 10 | 138 | 108 | 16 | 353 | |
| Alessandra Matteucci | 130 | 71 | 6 | 88 | 94 | 10 | 366 | |
| Bolati Kuerban | 177 | 69 | 1 | 183 | 46 | 17 | 402 | |
| Enji Zhang | 130 | 104 | 1 | 151 | 44 | 19 | 373 | |
| Simona Ospitalieri | 176 | 56 | 5 | 250 | 116 | 19 | 407 | |
| Nazaret Gamez | 163 | 65 | 6 | 184 | 44 | 14 | 398 | |
| Edwin Vázquez‐Rosa | 206 | 80 | 11 | 49 | 89 | 21 | 390 | |
| Shih‐Chang Hsueh | 145 | 70 | 7 | 80 | 94 | 19 | 384 | |
| Danielle N. Lyons | 162 | 116 | 1 | 226 | 80 | 12 | 383 | |
| Sarah Svirsky | 105 | 45 | 5 | 159 | 49 | 18 | 401 | |
| Zhong Wang | 164 | 30 | 14 | 77 | 123 | 18 | 407 |
All Works
Loading papers...